Log In
Print
BCIQ
Print
Print this Print this
 

SGN-CD70A

  Manage Alerts
Collapse Summary General Information
Company Seattle Genetics Inc.
DescriptionAntibody-drug conjugate (ADC) composed of an anti-CD70 mAb attached to a pyrrolobenzodiazepine (PBD) dimer
Molecular Target CD70 (CD27L)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today